Mechanisms of Infectious Disease

Equine Internal Medicine: Second Edition

Volumn , Issue , 2003, Pages 59-109

  Long, Maureen T ^a   Oaks, J Lindsay ^b   Rikihisa, Yasuko ^c  

^a University of Florida   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28544451134     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-169777-1/50004-4     Document Type: Chapter

References (442)

1. Sharp SE Commensal and pathogenic organisms. Manual of clinical microbiology 1999, ASM Press, Washington, DC. P.R. Murray, E.J. Barron, M.A. Pfaller (Eds.).
2. Scott DW Structure and function of the skin. Large animal dermatology 1988, WB Saunders, Philadelphia.
3. Scott DW Bacteria and yeast on the surface and within non-inflamed hair follicles of skin biopsies from dogs with non-neoplastic dermatoses. Cornell Vet 1992, 82:379.
4. Galuppo LD, Pascoe JR, Jang SS, et al. Evaluation of iodophor skin preparation techniques and factors influencing drainage from ventral midline incisions in horses. J Am Vet Med Assoc 1999, 215:963-969.
5. Devriese LA, Nzuambe D, Godard C Identification and characteristics of staphylococci isolated from lesions and normal skin of horses. Vet Microbiol 1985, 10:269.
6. Bailey GD, Love DN Oral associated bacterial infection in horses: studies on the normal anaerobic flora from the pharyngeal tonsilar surface and its association with lower respiratory tract and paraoral infections. Vet Microbiol 1991, 15:367-379.
7. Crane SA, Ziemer EL, Sweeney CR Cytologic and bacteriologic evaluation of tracheobronchial and aspirates from clinically normal foals. Am J Vet Res 1989, 50:2042.
8. Moore CP, Heller N, Majors LJ, et al. Prevalence of ocular microorganisms in hospitalized and stabled horses. Am J Vet Res 1988, 49:773.
9. Koopman JP, Kennis HM, Millink JW, et al. Normalization of germ free mice with anaerobically cultured ceacal flora of normal mice. Lab Anim 1984, 18:188.
10. Blumberg RS, Saubermann LJ, Strober W Animal models of inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999, 11:648.
11. Makie RI, Wilkins CA Enumeration of anearobic bacterial microflora of the equine gastrointestinal tract. Appl Environ Microbiol 1988, 54:2155.
12. Yuki N, Shimazaki T, Kushiro A, et al. Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactobacilli. Appl Environ Microbiol 2000, 66:5030.
13. Davies MK Studies on the microbial flora of the large intestine of the horse by continuous culture in an artificial colon. Vet Sci Commun 1979, 3:39.
14. Jullinand V, De Vaux A, Millet L, et al. Identification of Ruminococcus flavefaciens as the predominant cellulolytic bacteria species of the equine cecum. Appl Environ Microbiol 1999, 65:3738.
15. Maczulak AE, Dawson KA, Baker JP Nitrogen utilization in bacterial isolates from the equine cecum. Appl Environ Microbiol 1985, 50:1439.
16. Orpin CG Isolation of cellulolytic phycomycete fungi from the caecum of the horse. J Gen Microbiol 1981, 123:287.
17. Traub-Dargatz JL, Garber LP, Fedorka-Cray PJ, et al. Fecal shedding of Salmonella spp. by horses in the United States during 1998 and 1999 and detection of Salmonella spp. in grain and concentrate sources on equine operations. J Am Vet Med Assoc 2000, 217:226.
18. Weese JS, Staempfli HR, Prescott JF A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea. Equine Vet J 2001, 33:403.
19. Nakazawa M, Sugimoto C, Isayama Y Quantitative culture of Rhodococcus equi from the feces of the horse. Natl Inst Anim Health Q (Tokyo) 1983, 23:67.
20. Woolcock JB, Mutimer MD, Farmer AM Epidemiology of Corynebacterium in horses. Res Vet Sci 1980, 28:87.
21. Hinrichs K, Cummings MF, Sertrich PL, et al. Clinical significance of aerobic bacterial flora of the uterus, vagina, vestibule and clitoral fossa of clinically normal mares. J Am Vet Med Assoc 1988, 193:75.
22. Madsen M, Christensen P Bacterial flora of semen collected from Danish warmblood stallions by artificial vagina. Acta Vet Scand 1995, 36:1.
23. Platt H, Atherton JG, Orskov L Klebsiella and Enterobacter organisms isolated from horses. J Hyg 1976, 77:401.
24. Newcombe JR Comparison of the bacterial flora of three sites in the genital tract of the mare. Vet Rec 1978, 102:169-170.
25. Giampaolo C, Scheld M, Boyd J, et al. Leukocyte and bacterial interrelationships in experimental meningitis. Ann Neurol 1981, 9:328.
26. Emslie KR, Ozanne NR, Nade SM Acute haematogenous osteomyelitis: an experimental model. J Pathol 1983, 141:157.
27. Sanden G, Ljungh A, Wadstrom T, et al. Staphylococcal wound infection in the pig. II. Inoculation, quantification of bacteria and reproducibility. Ann Plast Surg 1989, 23:219.
28. Smith BP, Habasha F, Reina-Guerra, et al. Bovine salmonellosis: experimental production and characterization of the disease in calves, using oral challenge with Salmonella typhoid. Am J Vet Res 1979, 40:1510.
29. Dorn R Escherichia coli 0157:H7. J Am Vet Med Assoc 1995, 206:1583.
30. Domenico P, Johanson WG Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun 2001, 37:327.
31. Neu HC The crisis in antibiotic resistance. Science 1992, 257:1064.
32. Finland M Emergence of antibiotic resistance in hospitals, 1935-1975. Rev Infect Dis 1979, 1:4.
33. Amsden GW, Amankwa K Pneumococcal resistance: the treatment challenge. Ann Pharmacother 2001, 35:480.
34. Charpentier E, Tuomanen E Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect 2000, 2:1855.
35. Gillespie SH Antibiotic resistance in the absence of selective pressure. Int J Antimicrob Agents 2001, 17:171.
36. Witte W Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999, 44(suppl A):1.
37. Goodson J, Tyznik WJ, Cline JH, et al. Effects of an abrupt diet change from hay to concentrate on microbial numbers and physical environment in the cecum of the pony. Appl Environ Microbiol 1988, 54:1946.
38. Gustafsson A, Baverud V, Gunnarsson A, et al. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J 1997, 29:314.
39. Owen RS, Fullerton J, Barnum DA Effects of transportation, surgery and antibiotic therapy in ponies infected with Salmonella. Am J Vet Res 1983, 44:46.
40. Baverud V, Gustafsson A, Franklin A, et al. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997, 29:279.
41. Wilson DA, Macfadden KE, Green EM, et al. Case control and historical cohort study of diarrhea associated with administration of trimethoprim-potentiated sulphonamides to horses and ponies. J Vet Intern Med 1996, 10:258.
42. Hogenauer C, Hammer HF, Krejs GJ, et al. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998, 27:702.
43. Peeters TL, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989, 257:G470.
44. Lester GD, Merrit AM, Neuwirth L, et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. Am J Vet Res 1998, 58:328.
45. Austin SM, Foreman JH, Hungerford LL Case-control study of risk factors for development of pleuropneumonia in horses. J Am Vet med Assoc 1995, 1995:325.
46. Raidal SL, Love DN, Bailey GD Inflammation and increased numbers of bacteria in the lower respiratory tract of horses within 6 to 12 hours of confinement with the head elevated. Aust Vet J 1995, 72:45.
47. Raidal SL, Bailey GD, Love DN Effect of transportation and lower respiratory tract contamination and peripheral blood neutrophil function. Aust Vet J 1997, 75:433.
48. Gaynes R, Richards C, Edwards J, et al. Feeding back surveillance date to prevent hospital-acquired infections. Emerg Infect Dis 2001, 7:295.
49. Boerlin P, Eugster S, Gaschen F, et al. Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 2001, 82:347.
50. Ikeda JS, Hirsh DC Common plasmid encoding resistance to ampicillin, chloramphenical, gentamicin, and trimethroprim-sulfadiazine in two serotypes of Salmonella isolated during and outbreak of equine salmonellosis. Am J Vet Res 1985, 46:769.
51. Weese JS, Baird JD, Poppe C, et al. Emergence of Salmonella typhimurium definitive type 104 (DT 104) as an important cause of salmonellosis in horses in Ontario. Can Vet J 2001, 42:788.
52. Hartmann FA, West SE Antimicrobial susceptibility of profiles of multidrug-resistant Salmonella anatum isolated from horses. J Vet Diagn Invest 1995, 7:156-161.
53. Walker RF, Madigan JE, Hird DW, et al. An outbreak of equine neonatal salmonellosis. J Vet Diagn Invest 1991, 3:223.
54. Begg AP, Johnston KG, Hutchins DR, et al. Some aspects of the epidemiology of equine salmonellosis. Aust Vet J 1988, 65:221.
55. Vaaneechoutte M, Devriese LA, Dijkshoorn L, et al. Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol 2000, 38:4280.
56. Koterba A, Torchia J, Siverthorne C, et al. Nosocomial infections and bacterial antibiotic resistance in a university equine hospital. J Am Vet Med Assoc 1986, 189:185.
57. MacDonald DG, Morley PS, Bailey JV An examination of the occurrence of surgical wound infection following equine orthopaedic surgery. Equine Vet J 1994, 26:323.
58. Hartmann FA, Trostle SS, Klohnen AA Isolation of methicillin-resistant Staphylococcus aureus from a postoperative wound infection in a horse. J Am Vet Med Assoc 1997, 211:590.
59. Colahan PT, Peyton LC, Connelly MR, et al. Serratia spp. infection in 21 horses. J Vet Med Sci 1984, 185:209.
60. Amavisit P, Markham PF, Lightfoot D, et al. Molecular epidemiology of Salmonella Heidelberg in an equine hospital. Vet Microbiol 2001, 80:85.
61. Smyth CJ, Marron MB, Twohig JMGJ, et al. Fimbrial adhesins: similarities and variations in structure and biogenesis. FEMS Immunol Med Microbiol 1996, 16:127.
62. Fernandez LA, Berenguer J Secretion and assembly of regular surface structures in gram-negative bacteria. FEMS Microbiol Rev 2000, 24:21.
63. Hultgren SJ, Abraham S, Caparon M, et al. Pilus and non-pilus bacterial adhesins: assembly and function in cell recognition. Cell 1993, 73:887.
64. Salyers AA, Whitt DD Virulence factors that promote colonization. Bacterial pathogenesis 1994, ASM Press, Washington, DC.
65. Wu H, Fives-Taylor PM Molecular strategies for fimbrial expression and assembly. Crit Rev Oral Biol Med 2001, 12:101.
66. Holland RE, Grimes SD, Walker RD, et al. Experimental inoculation of foals and pigs with an enterotoxigenic E. coli isolated from a foal. Vet Microbiol 1996, 52:249.
67. Tasteyr A, Barc MC, Collignon A, et al. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 2001, 69:7937.
68. Wizemann TM, Moskovitz J, Pearce BJ, et al. Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A 1996, 93:7985.
69. Wizemann TM, Heinrichs JH, Adamou JE, et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001, 69:1593.
70. Van Der FM, Chhun N, Wizemann TM, et al. Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect Immun 1995, 63:4317.
71. Gilot P, Andre P, Content J Listeria monocytogenes possesses adhesins for fibronectin. Infect Immun 1999, 67:6698.
72. Sinha B, Francois PP, Nusse O, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin α5β1. Cell Microbiol 1999, 1:101.
73. Sinha B, Francois P, Que YA, et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun 2000, 68:6871.
74. Rich RL, Kreikemeyer B, Owens RT, et al. Ace is a collagen-binding MSCRAMM from Enterococcus faecalis. J Biol Chem 1999, 274:26939.
75. Wizemann TM, Adamou JE, Langermann S Adhesins as targets for vaccine development. Emerg Infect Dis 1999, 5:395.
76. Srivastava SK, Barnum DA The role of lipoteichoic acids on the adherence of Streptococcus equi to epithelial cells. Vet Microbiol 1983, 8:485.
77. Colombo AV, Hirata R, De Souza CM, et al. Corynebacterium diphtheriae surface proteins as adhesins to human erythrocytes. FEMS Microbiol Lett 2001, 197:235.
78. Bierne H, Gouin E, Roux P, et al. A role for cofilin and LIM kinase in Listeria-induced phagocytosis. J Cell Biol 2001, 155:101.
79. Zhou D, Mooseker MS, Galan JE An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc Natl Acad Sci U S A 1999, 96:10176.
80. Reddy VM, Kumar B Interaction of Mycobacterium avium complex with human respiratory epithelial cells. J Infect Dis 2000, 181:1189.
81. Sangari FJ, Goodman J, Bermudez LE Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype. Cell Microbiol 2000, 2:561.
82. Mulholland K, Smith PG, Broome CV, et al. A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia: ethical considerations. Int J Tuberc Lung Dis 1999, 3:749.
83. Lagos R, Horwitz I, Toro J, et al. Large scale, post licensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996, 15:216.
84. Whitfield C, Roberts IS Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 1999, 31:1307.
85. Amako K, Meno Y, Takade A Fine structures of the capsules of Klebsiella pneumoniae and Escherichia coli K1. J Bacteriol 1988, 170:4960.
86. Bortolussi R, Ferrieri P, Quie PG Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization. Infect Immun 1983, 39:1136.
87. Guze LB, Harwick HJ, Kalmanson GM Klebsiella L-forms: effect of growth as L-form on virulence of reverted Klebsiella pneumoniae. J Infect Dis 1976, 133:245.
88. Takahashi M, Yoshida K, San Clemente CL Relation of colonial morphologies in soft agar to morphological and biological properties of the K-9 strain of Klebsiella pneumoniae and its variants. Can J Microbiol 1977, 23:448.
89. Horwitz MA, Silverstein SC Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest 1980, 65:82.
90. Wacharotayankun R, Arakawa Y, Ohta M, et al. Enhancement of extra capsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun 1993, 61:3164.
91. Griffith F The significance of pneumococcal types. J Hyg 1928, 27:113-159.
92. Avery OT, MacLoeon DM, McCarty M Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1944, 79:137.
93. Srivastava SK, Barnum DA, Prescott JF Production and biological properties of M-protein of Streptococcus equi. Res Vet Sci 1985, 38:184.
94. Gilmour MI, Park PI, Selgrad MK Ozone-enhanced pulmonary infection with Streptococcus zooepidemicus in mice: the role of alveolar macrophage function and capsular virulence factors. Am Rev Resp Dis 1993, 147:753.
95. Anzai T, Timoney JF, Kuwamoto Y, et al. In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Vet Microbiol 1999, 67:277.
96. Chanter N, Ward CL, Talbot NC, et al. Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice. Microb Pathog 1999, 27:133.
97. Tzianabos AO, Kasper DL, Onderdonk AB Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis 1995, 20(suppl 2):S132.
98. Patrick S, Lutton DA, Crockard AD Immune reactions to Bacteroides fragilis populations with three different types of capsule in a model of infection. Microbiology 1995, 141(pt 8):1969.
99. Brook I The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev 1994, 13:65.
100. Brook I Encapsulated anaerobic bacteria in clinical infections. Zentralbl Bakteriol 1993, 279:443.
101. Tomas JM, Ciurana B, Benedi VJ, et al. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum. J Gen Microbiol 1988, 134(pt 4):1009.
102. Morrison DC, Brown DE, Vukajlovich SW, et al. Ganglioside modulation of lipopolysaccharide-initiated complement activation. Mol Immunol 1985, 22:1169.
103. Jagels MA, Travis J, Potempa J, et al. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun 1996, 64:1984.
104. Bohnsack JF, Mollison KW, Buko AM, et al. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem J 1991, 273(pt 3):635.
105. Bartholomew WR, Shanahan TC Complement components and receptors: deficiencies and disease associations. Immunol Ser 1990, 52:33.
106. Hill HR, Bohnsack JF, Morris EZ, et al. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol 1988, 141:3551.
107. Hoe NP, Kordari P, Cole R, et al. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis 2000, 182:1425.
108. Johnsson E, Berggard K, Kotarsky H, et al. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol 1998, 161:4894.
109. Mitchell TJ Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol 2000, 151:413.
110. Timoney JF, Artiushin SC, Boschwitz JS Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infect Immun 1997, 65:3600.
111. Boschwitz JS, Timoney JF Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. Infect Immun 1994, 62:3515.
112. Boschwitz JS, Timoney JF Characterization of the antiphagocytic activity of equine fibrinogen for Streptococcus equi subsp equi. Microb Pathog 1994, 17:121.
113. Goebel W, Chakraborty T, Domann E, et al. Studies on the pathogenicity of Listeria monocytogenes. Infection 1991, 19(suppl 4):S195.
114. Alvarez-Dominguez C, Roberts R, Stahl PD Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. J Cell Sci 1997, 110(pt 6):731.
115. Armstrong JA, Hart PD Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli: reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975, 142:1.
116. McDonough KA, Kress Y, Bloom BR The interaction of Mycobacterium tuberculosis with macrophages: a study of phagolysosome fusion. Infect Agents Dis 1993, 2:232.
117. Oh YK, Alpuche-Aranda C, Berthiaume E, et al. Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect Immun 1996, 64:3877.
118. Gallois A, Klein JR, Allen LA, et al. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol 2001, 166:5741.
119. Hietala SK, Ardans AA Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol 1987, 14:307.
120. Zink MC, Yager JA, Prescott JF, et al. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol 1987, 14:295.
121. Benoit S, Benachour A, Taouji S, et al. Induction of vap genes encoded by the virulence plasmid of Rhodococcus equi during acid tolerance response. Res Microbiol 2001, 152:439.
122. Hantke K Cloning of the repressor protein gene of iron-regulated systems in Escherichia coli K12. Mol Gen Genet 1984, 197:337.
123. Achenbach LA, Genova EG Transcriptional regulation of a second flavodoxin gene from Klebsiella pneumoniae. Gene 1997, 194:235.
124. Otto BR, Kusters JG, Luirink J, et al. Molecular characterization of a heme-binding protein of Bacteroides fragilis BE1. Infect Immun 1996, 64:4345.
125. Heidrich C, Hantke K, Bierbaum G, et al. Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis. FEMS Microbiol Lett 1996, 140:253.
126. Prince RW, Storey DG, Vasil AI, et al. Regulation of toxA and regA by the Escherichia coli fur gene and identification of a fur homologue in Pseudomonas aeruginosa PA103 and PA01. Mol Microbiol 1991, 5:2823.
127. Goldberg MB, Boyko SA, Calderwood SB Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholera. Proc Natl Acad Sci U S A 1991, 88:1125.
128. Neilands JB Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 1995, 270:26723.
129. Salyers AA, Whitt DD Disease without colonization: food-borne toxicoses caused by Clostridium botulinum, Staphylococcus aureus, and Clostridium perfringens. Bacterial pathogenesis 1994, ASM Press, Washington, DC.
130. Dinges MM, Orwin PM, Schlievert PM Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000, 13:16.
131. Shimizu A, Kawano J, Ozaki J, et al. Characteristics of Staphylococcus aureus isolated from lesions of horses. J Vet Med Sci 1991, 53:601-606.
132. Sato H, Matsumori Y, Tanabe T, et al. A new type of staphylococcal exfoliative toxin from Staphylococcus aureus strain isolated from a horse with phlegmon. Infect Immun 1994, 62:3780.
133. Critchley EMR A comparison of human and animal botulism: a review. J Royal Soc Med 1991, 84:295.
134. Ricketts SW, Greet TRC, Glyn PJ, et al. Thirteen cases of botulism in horses fed big bale silage. Equine Vet J 1984, 16:515.
135. Kelley AP, Jones RT, Gillick JC, et al. Outbreak of botulism in horses. Equine Vet J 1984, 16:519.
136. Swerczek TW Toxicoinfectious botulism in foals and adult horses. J Am Vet Med Assoc 1980, 176:217.
137. Wichtel JJ, Whitlock RH Botulism associated with feeding alfalfa hay to horses. J Am Vet Med Assoc 1991, 199:471.
138. Hathaway P Toxigenic clostridia. Clin Microbiol Rev 1990, 3:66.
139. Kaneo M, Inoue S, Abe T, et al. Isolation of Clostridium perfringens from foals. Microbios 1990, 64:153.
140. Donaldson MT, Palmer JE Prevalence of Clostridium perfringens enterotoxin and Clostridium difficile toxin A in feces of horses with diarrhea and colic. J Am Vet Med Assoc 1999, 215:358.
141. Howard-Martin M, Morton RJ, Qualls CW, et al. Clostridium perfringens type C enterotoxemia in a newborn foal. J Am Vet Med Assoc 1986, 189:564.
142. Montgomery RF, Rowlands WT "Lamb dysentery" in a foal. Vet Rec 1937, 189:398.
143. Alape-Giron A, Flores-Diaz M, Guillouard I, et al. Identification of residues critical for toxicity of Clostridium perfringens phospholipase C, the key toxin in gas gangrene. Eur J Biochem 2000, 267:5191.
144. Rood JI Virulence genes of C. perfringens. Annu Rev Microbiol 1998, 52:330.
145. Tweten RK Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol 2001, 82:1.
146. Petit L, Maier E, Gilber M, et al. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 2001, 276:15736.
147. Herholz C, Miserez R, Nocolet J, et al. Prevalence of beta2-toxigenic Clostridium perfringens in horses with intestinal disorders. J Clin Microbiol 1999, 37:358.
148. Pothoulakis C, Lamont JT Microbes and microbial toxins: paradigms for microbial-mucosal interactions. II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 2001, 2:G178.
149. Borriello SP Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 1998, 41(suppl C):13.
150. Jefferson KK, Smith MF, Bobak DA Roles of intracellular calcium and NF-kappa-Beta in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J Immunol 1999, 163:5183.
151. Feltis BA, Wiesner SM, Kim AS, et al. Clostridium difficile toxins A and B can alter the epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes. Shock 2000, 14:629.
152. Gao LY, Kwaik YA The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 2000, 8:306.
153. Grassme H, Jendrossek V, Gulbins E Molecular mechanisms of bacteria induced apoptosis. Apoptosis 2001, 6:441.
154. Yrlid U, Wick MJ Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 2000, 191:613.
155. Dixon DM, Rhodes JC, Fromtling RA Taxonomy, classification, and morphology of the fungi. Manual of clinical microbiology 1999, ASM Press, Washington, DC. P.R. Murray, E.J. Baron, M. Pfaller (Eds.).
156. Bulawa CE, Miller DW, Henry LK, et al. Attenuated virulence of chitin-deficient mutants of Candida albicans. Proc Natl Acad Sci U S A 1995, 92:10570.
157. Buurman ET, Westwater C, Hube B, et al. Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proc Natl Acad Sci U S A 1998, 95:7670.
158. Fu Y, Rieg G, Fonzi WA, et al. Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells. Infect Immun 1998, 66:1783.
159. Gale CA, Bendel CM, McClellan M, et al. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 1998, 279:1355.
160. Kinneberg KM, Bendel CM, Jechorek RP, et al. Effect of INT1 gene on Candida albicans murine intestinal colonization. J Surg Res 1999, 87:245.
161. Newman SL, Chaturvedi S, Klein BS The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol 1995, 154:753.
162. Fries BC, Taborda CP, Serfass E, et al. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001, 108:1639.
163. Rotrosen D, Edwards JE, Gibson TR, et al. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis 1985, 152:1264.
164. Eissenberg LG, Goldman WE Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun 1987, 55:29.
165. Eissenberg LG, Schlesinger PH, Goldman WE Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J Leukoc Biol 1988, 43:483.
166. Eissenberg LG, Poirier S, Goldman WE Phenotypic variation and persistence of Histoplasma capsulatum yeasts in host cells. Infect Immun 1996, 64:5310.
167. Lo HJ, Kohler JR, Didomenico B, et al. Nonfilamentous C. albicans mutants are avirulent. Cell 1997, 90:939.
168. Kvaal C, Lachke SA, Srikantha T, et al. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 1999, 67:6652.
169. Kvaal CA, Srikantha T, Soll DR Misexpression of the white-phase-specific gene WH11 in the opaque phase of Candida albicans affects switching and virulence. Infect Immun 1997, 65:4468.
170. Eissenberg LG, Moser SA, Goldman WE Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophages or epithelial cells. J Infect Dis 1997, 175:1538.
171. Fries BC, Goldman DL, Cherniak R, et al. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun 1999, 67:6076.
172. Cruz MC, Sia RA, Olson M, et al. Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans. Infect Immun 2000, 68:982.
173. Joseph JD, Heitman J, Means AR Molecular cloning and characterization of Aspergillus nidulans cyclophilin B. Fungal Genet Biol 1999, 27:55.
174. De Bernardis F, Muhlschlegel FA, Cassone A, et al. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun 1998, 66:3317.
175. Doering TL, Nosanchuk JD, Roberts WK, et al. Melanin as a potential cryptococcal defense against microbicidal proteins. Med Mycol 1999, 37:175.
176. Howard DH Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev 1999, 12:394.
177. Holzberg M, Artis WM Hydroxamate siderophore production by opportunistic and systemic fungal pathogens. Infect Immun 1983, 40:1134.
178. Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect 2001, 16:91.
179. Sebghati TS, Engle JT, Goldman WE Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science 2000, 290:1368.
180. Van Burik JA, Magee PT Aspects of fungal pathogenesis in humans. Annu Rev Microbiol 2001, 55:743.
181. Hube B Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996, 7:55.
182. Resnick S, Pappagianis D, McKerrow JH Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infect Immun 1987, 55:2807.
183. Yuan L, Cole GT Isolation and characterization of an extracellular proteinase of Coccidioides immitis. Infect Immun 1987, 55:1970.
184. Yu JJ, Smithson SL, Thomas PW, et al. Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis. Gene 1997, 198:387.
185. Iadarola P, Lungarella G, Martorana PA, et al. Lung injury and degradation of extracellular matrix components by Aspergillus fumigatus serine proteinase. Exp Lung Res 1998, 24:233.
186. Rodriguez E, Boudard F, Mallie M, et al. Murine macrophage elastolytic activity induced by Aspergillus fumigatus strains in vitro: evidence of the expression of two macrophage-induced protease genes. Can J Microbiol 1997, 43:649.
187. Ghannoum MA Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000, 13:122.
188. Mitrovic S, Kranjcic-Zec I, Arsic V, et al. In vitro proteinase and phospholipase activity and pathogenicity of Candida species. J Chemother 1995, 4(suppl):43.
189. Prakobphol A, Leffler H, Hoover CI, et al. Palmitoyl carnitine, a lysophospholipase-transacylase inhibitor, prevents Candida adherence in vitro. FEMS Microbiol Lett 1997, 151:89.
190. Noverr MC, Toews GB, Huffnagle GB Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 2002, 70:400.
191. Mendes-Giannini MJ, Taylor ML, Bouchara JB, et al. Pathogenesis II: fungal responses to host responses-interaction of host cells with fungi. Med Mycol 2000, 38(suppl 1):113.
192. Golden MC, Hahm SJ, Elessar RE, et al. DNA damage by gliotoxin from Aspergillus fumigatus: an occupational and environmental propagule-adduct detection as measured by 32P DNA radiolabelling and two-dimensional thin-layer chromatography. Mycoses 1998, 41:97.
193. Crawford TB Equine adenovirus. Veterinary diagnostic virology 1992, Mosby-Year Book, St Louis. A.E. Castro, W.P. Heuschele (Eds.).
194. Herbst W, Gorlich P, Danner K Virologico-serologic studies in horses with respiratory tract diseases. Berl Munch Tierarztl Wochenschr 1992, 105:49.
195. Telford EAR, Studdert MJ, Agius CT, et al. Equine herpesviruses 2 and 5 are gamma-herpesviruses. Virology 1993, 195:492.
196. Bock M, Stoye JP Endogenous retroviruses and the human germline. Curr Opin Genet Dev 2000, 10:651.
197. Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust 1995, 162:642.
198. Renshaw RW, Glaser AL, Van Campen H, et al. Identification and phylogenetic comparison of Salem virus, a novel paramyxovirus of horses. Virology 2000, 270:417.
199. Carr EA, Theon AP, Madewell BR, et al. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 2001, 62:741.
200. Carr EA, Theon AP, Madewell BR, et al. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 2001, 62:1212.
201. Tennant B Acute hepatitis in horses: problems of differentiating toxic and infectious causes in the adult. Proc Am Assoc Equine Pract 1978, 24:465.
202. Tomlinson MJ, Doster AR, Wright ER Lymphosarcoma with virus-like particles in a neonatal foal. Vet Pathol 1979, 16:629.
203. Mason A Viral induction of type 2 diabetes and autoimmune liver disease. J Nutr 2001, 131:2805S.
204. Dhurandhar NV Infectobesity: obesity of infectious origin. J Nutr 2001, 131:2794S.
205. Murray MJ, del Piero F, Jeffrey SC, et al. Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. J Vet Intern Med 1998, 12:36.
206. Rees WA, Harkins JD, Lu M, et al. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res 1999, 60:888.
207. Veterinary virology 1999, Academic Press, San Diego. F.A. Murphy, E.P.J. Gibbs, M.C. Horzinek (Eds.).
208. Virology: molecular biology, pathogenesis, and control 2000, ASM Press, Washington, DC. S.J. Flint, L.W. Enquist, R.M. Krug (Eds.).
209. De Clercq E In search of a selective antiviral chemotherapy. Clin Microbiol Rev 1997, 10:674.
210. Bean B Antiviral therapy: current concepts and practices. Clin Microbiol Rev 1992, 5:146.
211. Preston BD, Dougherty JP Mechanisms of retroviral mutation. Trends Microbiol 1996, 4:16.
212. Domingo E, Baranowski E, Ruiz-Jarabo CM Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 1998, 4:521.
213. Scholtissek C Molecular epidemiology of influenza. Arch Virol 1997, 13(suppl):99.
214. Steinhauer DA Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999, 258:1.
215. Skehel JJ, Wiley DC Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531.
216. Ito T, Kawaoka Y Host-range barrier of influenza A viruses. Vet Microbiol 2000, 74:71.
217. Kuhlenschmidt MS, Rolsma MD, Kuhlenschmidt TB, et al. Characterization of a porcine enterocyte receptor for group A rotavirus. Adv Exp Med Biol 1997, 412:135.
218. Weinstein L Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. N Engl J Med 1957, 257:47.
219. De Beek O, Caillet-Fauquet Viruses and the cell cycle. Prog Cell Cycle Res 1997, 3:1.
220. Sinclair J, Baille J, Bryant L, et al. Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells. J Gen Virol 2000, 81:1553.
221. Berns KI Parvovirus replication. Microbiol Rev 1990, 54:316.
222. Puvion-Dutilleul F, Besse S, Pichard E, et al. Release of viruses and viral DNA from nucleus to cytoplasm of HeLa cells at late stages of productive adenovirus infection as revealed by electron microscope in situ hybridization. Biol Cell 1998, 90:5.
223. Thomson BJ Viruses and apoptosis. Int J Exp Pathol 2001, 82:65.
224. Moore M, Horikoshi N, Shenk T Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci U S A 1996, 93:11295.
225. Sullivan DC, Atherton SS, Caughman GB, et al. Oncogenic transformation of primary hamster embryo cells by equine herpesvirus type 3. Virus Res 1986, 5:201.
226. de The Gde Epstein-Barr virus and associated diseases: course of medical virology, Institut Pasteur, 1995/1996. Ann Med Interne (Paris) 1997, 148:357.
227. Burmeister T Oncogenic retroviruses in animals and humans. Rev Med Virol 2001, 11:369.
228. Haig DM Subversion and piracy: DNA viruses and immune evasion. Res Vet Sci 2001, 70:205.
229. Young DF, Didcock L, Goodbourn S, et al. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 2000, 10:383.
230. Xiao-Ning X, Screaton GR, McMichael AJ Virus infections: escape, resistance, and counterattack. Immunity 2001, 15:867.
231. Tomasec P, Braud VM, Richards C, et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287:1031.
232. Haig DM Poxvirus interference with the host cytokine response. Vet Immunol Immunopathol 1998, 63:149.
233. Garcia-Blanco MA, Cullen BR Molecular basis of latency in pathogenic human viruses. Science 1991, 254:815.
234. Welch HM, Bridges CG, Lyon AM, et al. Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 1992, 73:261.
235. Borchers K, Wolfinger U, Lawrenz B, et al. Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. J Gen Virol 1997, 78:1109.
236. Edington N, Bridges CG Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 1985, 17:369.
237. Padgett DA, Sheridan JF, Dorne J, et al. Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci U S A 1998, 95:7231.
238. Chowdhury SI, Kubin G, Ludwig H Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lippizaner stud: a contribution to the classification of equine herpesviruses. Arch Virol 1986, 90:273.
239. Matsumura T, Kondo T, Sugita S, et al. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology 1998, 242:68.
240. Crawford TB, Wardrop KJ, Tornquist SJ, et al. A primary production deficit in the thrombocytopenia of equine infectious anemia. J Virol 1996, 70:7842.
241. Oaks JL, McGuire TC, Ulibarri C, et al. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J Virol 1998, 72:7263.
242. Maury W, Perryman S, Oaks JL, et al. Localized sequence heterogeneity in the LTR of in vivo isolates of equine infectious anemia virus. J Virol 1997, 71:4929.
243. Belshan M, Baccam P, Oaks JL, et al. Genetic and biological variation in equine infectious anemia virus rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 2001, 279:185.
244. Jacob RJ, Price R, Bouchey D, et al. Temperature sensitivity of equine herpesvirus isolates: a brief review. SAAS Bull Biochem Biotechnol 1990, 3:124.
245. Gaskell R, Dawson S Feline respiratory diseases. Infectious diseases of the dog and cat 1998, WB Saunders, Philadelphia. C.E. Greene (Ed.).
246. Younger JS, Whitaker-Dowling P, Chambers TM, et al. Derivation and characterization of a live attenuated equine influenza vaccine virus. Am J Vet Res 2001, 62:1290.
247. Cravens RL, Ellsworth MA, Sorensen CD, et al. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers. J Am Vet Med Assoc 1996, 208:2031.
248. Fenner F Mousepox (infectious ectromelia of mice): a review. J Immunol 1949, 63:341.
249. Calisher CH Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994, 7:89.
250. Walker C, Love DN, Whalley JM Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review. Vet Microbiol 1999, 68:3.
251. Edington N, Smyth B, Griffiths L The role of endothelial cell infection in the endometrium, placenta and foetus of equid herpesvirus 1 (EHV-1) abortions. J Comp Pathol 1991, 104:379.
252. Whitwell KE, Blunden AS Pathological findings in horses dying during an outbreak of the paralytic form of equid herpesvirus type 1 (EHV-1) infection. Equine Vet J 1992, 24:13.
253. Green SL Rabies. Vet Clin North Am Equine Pract 1997, 13:1.
254. Baxi MK, Efstathiou S, Lawrence G, et al. The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J Gen Virol 1995, 76:3113.
255. Sutton GA, Viel L, Carman PS, et al. Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo. Can J Vet Res 1998, 62:49.
256. Yates WD A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 1982, 46:225.
257. Allan JE, Dixon JE, Doherty PC Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis. Curr Top Microbiol Immunol 1987, 134:131.
258. Clabough DL, Gebhard D, Flaherty MT, et al. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J Virol 1991, 65:6242.
259. Clabough DL The immunopathogenesis and control of equine infectious anemia. Equine Pract 1990, 85:1020.
260. Sullivan NJ Antibody-mediated enhancement of viral disease. Curr Top Microbiol Immunol 2001, 260:145.
261. Hohdatsu T, Yamada M, Tominaga R, et al. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus. J Vet Med Sci 1998, 60:49.
262. Openshaw PJ, Culley FJ, Olszewska W Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 2001, 20(suppl 1):S27.
263. Mady BJ, Erbe DV, Kurane I, et al. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol 1991, 147:3139.
264. Van Reeth K Cytokines in the pathogenesis of influenza. Vet Microbiol 2000, 74:109.
265. Herbein G, O'Brien WA Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med 2000, 223:241.
266. Tornquist SJ, Oaks JL, Crawford TB Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia. J Gen Virol 1997, 78:2541.
267. Winer JB Guillain Barre syndrome. Mol Pathol 2001, 54:381.
268. Nolte KB, Alakija P, Oty G, et al. Influenza A virus infection complicated by fatal myocarditis. Am J Forensic Med Pathol 2000, 21:375.
269. Evermann JF, Heeney JL, Roelke ME, et al. Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah. Arch Virol 1988, 102:155.
270. Murakami T, Yamamoto N Roles of cytokines and chemokine receptors in HIV-1 infection. Int J Hematol 2000, 72:412.
271. Carrington M, Nelson G, O'Brien SJ Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol Lett 2001, 79:131.
272. Crowe JE, Suara RO, Brock S, et al. Genetic and structural determinants of virus neutralizing antibodies. Immunol Res 2001, 23:135.
273. Copeland KF, Heeney JL T helper cell activation and human retroviral pathogenesis. Microbiol Rev 1996, 60:722.
274. Brown WC, Rice-Ficht AC, Estes DM Bovine type 1 and type 2 responses. Vet Immunol Immunopathol 1998, 63:45.
275. Karupiah G Type 1 and type 2 cytokines in antiviral defense. Vet Immunol Immunopathol 1998, 63:105.
276. Kong XG, Pang H, Sugiura T, et al. Evaluation of equine infectious anemia virus core proteins produced in a baculovirus expression system in agar gel immunodiffusion test and enzyme-linked immunosorbent assay. J Vet Med Sci 1998, 60:1361.
277. Soutullo A, Verwimp V, Riveros M, et al. Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides. Vet Microbiol 2001, 79:111.
278. Kanai K, Nunoya T, Shibuya K, et al. Variations in effectiveness of antigen retrieval pretreatments for diagnostic immunohistochemistry. Res Vet Sci 1998, 64:57.
279. Patteson JS, Maes RK, Mullaney TP, et al. Immunohistochemical diagnosis of eastern equine encephalomyelitis. J Vet Diagn Invest 1996, 8:156.
280. Del Piero F Diagnosis of equine arteritis virus infection in two horses by using monoclonal antibody immunoperoxidase histochemistry on skin biopsies. Vet Pathol 2000, 37:486.
281. Hooper PT, Russell GM, Selleck PW, et al. Immunohistochemistry in the identification of a number of new diseases in Australia. Vet Microbiol 1999, 68:89.
282. Belak S, Thoren P Molecular diagnosis of animal diseases: some experiences over the past decade. Expert Rev Mol Diagn 2001, 1:434.
283. Mackay IM, Arden KE, Nitsche A Real-time PCR in virology. Nucleic Acids Res 2002, 30:1292.
284. Jacobs DE A colour atlas of equine parasites 1986, Lea & Febiger, Philadelphia.
285. Symons Lea Pathophysiology of endoparasitic infection compared with ectoparasitic infestation and microbial infection 1989, Academic Press, San Diego.
286. Slocombe JOD Pathogenesis of helminths in equines. Vet Parasitol 1985, 18:139.
287. Herd RP The veterinary clinics of North America equine practice, vol 2, Parasitology, 1986, WB Saunders, Philadelphia.
288. McCraw BM, Slocombe JOD Early development of Strongylus vulgaris in pony foals. Proc Am Assoc Vet Parasitol 1990, 57. (abstract).
289. Klei TR, Turk MAM, McClure JR, et al. Effects of repeated experimental Strongylus vulgaris infections and subsequent ivermectin treatment on mesenteric arterial pathology in pony foals. Am J Vet Res 1990, 51:54.
290. Holmes RA, Klei TR, McClure JR, et al. Sequential mesenteric arteriography in pony foals during a course of repeated experimental Strongylus vulgaris infections and ivermectin treatments. Am J Vet Res 1990, 51:661.
291. Clayton HM Ascarids: recent advances. The veterinary clinics of North America equine practice, vol 2, Parasitology 1986, WB Saunders, Philadelphia. R.P. Herd (Ed.).
292. Beroza GA, Barclay WP, Phillips TN, et al. Cecal perforation and peritonitis associated with Anoplocephala perfoliata infection in three horses. J Am Vet Med Assoc 1983, 183:804.
293. Barclay WP, Phillips TN, Foerner JJ Intussusception associated with Anoplocephala perfoliata. Vet Rec 1989, 124:34.
294. Owen RR, Jagger DW, Quan-Taylor R Cecal intussusceptions in horses and the significance of Anoplocephala perfoliata. Vet Rec 1989, 124:34.
295. Proudman CJ, Edwards GB, Gareth B Are tapeworms associated with equine colic? a case control study. Equine Vet J 1993, 25:224.
296. Uhlinger CA Effects of three anthelmintic schedules on the incidence of colic. Equine Vet J 1991, 22:251.
297. Uhlinger CA Equine small strongyles: epidemiology, pathology and control. Comp Cont Educ Pract Vet 1991, 13:863.
298. Castro GA Immunophysiology of enteric parasitism. Parasitol Today 1989, 5:11.
299. Bueno L, Ruckenbusch Y, Dorchies PH Disturbances of digestive motility in horses associated with strongyle infection. Vet Parasitol 1979, 5:253.
300. Lester GD, Bolton JR, Cambridge H, et al. The effect of Strongylus vulgaris larvae on the equine intestinal myoelectrical activity. Equine Vet J Suppl 1989, 7:8.
301. Berry CR, Merrit AM, Burrows CF, et al. Evaluation of the myoelectrical activity of the equine ileum infected with Strongylus vulgaris larvae. Am J Vet Res 1986, 87:27.
302. Kaiser L, Tithof PK, Williams JF Depression of endothelium-dependent relaxation of filarial parasite products. Am J Physiol 1990, 254:H648.
303. McKenzie CD Immune responses in onchocerciasis and dracunculiasis. Immune responses in parasitic infections: immunology, immunopathology and immunoprophylaxis, vol 1, Nematodes, 1987, CRC Press, Boca Raton. E.J.L. Soulsby (Ed.).
304. King CL, Nutman TB Regulation of immune responses in lymphatic filariasis and onchocerciasis. Immunol Today 1991, 3:A54.
305. Loyd S, Soulsby EJL Immunobiology of gastrointestinal nematodes of ruminants. Immune responses in parasitic infections: immunology, immunopathology and immunoprophylaxis, vol 1, Nematodes 1987, CRC Press, Boca Raton. E.J.L. Soulsby (Ed.).
306. Foil LD, Klei TR, Miller RI, et al. Seasonal changes in density and tissue distribution of Onchocerca cervicalis microfilariae in ponies and related changes in Culicoides varnipennis populations in Louisiana. J Parasitol 1987, 73:320.
307. Ogbourne CP, Duncan JR: Strongylus vulgaris in the horse: its biology and veterinary importance, ed 2, Misc Pub No 9, St Albans, UK, Commonwealth Institute of Parasitology.
308. Murrell KD Induction of protective immunity to Strongyloides ransomi in pigs. Am J Vet Res 1981, 42:1915.
309. Dennis VA, Klei TR, Chapman MR, et al. In vivo activation of equine eosinophils and neutrophils by experimental Strongylus vulgaris infections. Vet Immunol Immunopathol 1988, 20:61.
310. Finkelman FD, Pearce EJ, Urban JF, et al. Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991, 12:A62.
311. Sher A, Colley DG Immunoparasitology. Fundamental immunology 1989, Raven Press, New York. ed 2. W.E. Paul (Ed.).
312. Loyd S Cysticercoses. Immune responses in parasitic infections: immunology, immunopathology and immunoprophylaxis, vol 2, Trematodes and cestodes 1987, CRC Press, Boca Raton. E.J.L. Soulsby (Ed.).
313. Liu LX, Weller PF Arachidonic acid metabolism in filarial parasites. Exp Parasitol 1990, 71:496.
314. Kohler P The biochemical basis of anthelmintic action and resistance. Int J Parasitol 2001, 31:336-345.
315. Ihler CF A field survey on anthelmintic resistance in equine small strongyles in Norway. Acta Vet Scand 1995, 36:135-143.
316. Jasmer DP, Yao C, Rehman A, et al. Multiple lethal effects induced by a benzimidazole anthelmintic in the anterior intestine of the nematode Haemonchus contortus. Mol Biochem Parasitol 2000, 105:81-90.
317. Roos MH, Kwa MS, Veenstra JG, et al. Molecular aspects of drug resistance in parasitic helminths. Pharmacol Ther 1993, 60:331-336.
318. Dent JA, Davis MW, Avery L avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 1997, 16:5867-5879.
319. Hejmadi MV, Jagannathan S, Delany NS, et al. L-glutamate binding sites of parasitic nematodes: an association with ivermectin resistance?. Parasitology 2000, 120(pt 5):535-545.
320. Jagannathan S, Laughton DL, Critten CL, et al. Ligand-gated chloride channel subunits encoded by the Haemonchus contortus and Ascaris suum orthologues of the Caenorhabditis elegans gbr-2 (avr-14) gene. Mol Biochem Parasitol 1999, 103:129-140.
321. Robertson AP, Bjorn HE, Martin RJ Resistance to levamisole resolved at the single-channel level. FASEB J 1999, 13:749-760.
322. Martin-Downum K, Yazwinski T, Tucker C, et al. Cyathostome fecal egg count trends in horses treated with moxidectin, ivermectin or fenbendazole. Vet Parasitol 2001, 101:75-79.
323. Tarigo-Martinie JL, Wyatt AR, Kaplan RM Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses. J Am Vet Med Assoc 2001, 218:1957-1960.
324. Chapman MR, French DD, Monahan CM, et al. Identification and characterization of a pyrantel pamoate resistant cyathostome population. Vet Parasitol 1996, 66:205-212.
325. Craven J, Bjorn H, Barnes EH, et al. A comparison of in vitro tests and a faecal egg count reduction test in detecting anthelmintic resistance in horse strongyles. Vet Parasitol 1999, 85:49-59.
326. Craven J, Bjorn H, Henriksen SA, et al. Survey of anthelmintic resistance on Danish horse farms, using 5 different methods of calculating faecal egg count reduction. Equine Vet J 1998, 30:289-293.
327. Lyons ET, Tolliver SC, Drudge JH, et al. Critical test evaluation (1977-1992) of drug efficacy against endoparasites featuring benzimidazole-resistant small strongyles (population S) in Shetland ponies. Vet Parasitol 1996, 66:67-73.
328. Herd RP, Coles GC Slowing the spread of anthelmintic resistant nematodes of horses in the United Kingdom. Vet Rec 1995, 136:481-485.
329. Lacey E, Gill JH Biochemistry of benzimidazole resistance. Acta Trop 1994, 56:245-262.
330. Knowles RC, Anderson CW, Shipley WD, et al. Acute equine diarrhea syndrome (AEDS): a preliminary report. Proc Annu Meet Am Assoc Equine Pract 1983, 29:353.
331. Madigan JE, Barlough JE, Rikihisa Y, et al. Identification of the "Shasta River Crud" syndrome as Potomac horse fever (equine monocytic ehrlichiosis). J Equine Vet Sci 1997, 17:270.
332. Holland CJ, Weiss E, Burgdorfer W, et al. Ehrlichia risticii sp. nov.: etiological agent of equine monocytic ehrlichiosis (synonym, Potomac horse fever). Int J Syst Bacteriol 1985, 35:524.
333. Dumler JS, Barbet AF, Bekker CPJ, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, description of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001, 51:2145.
334. Holland CJ, Ristic M, Cole AI, et al. Isolation, experimental transmission and characterization of causative agent of Potomac horse fever. Science 1985, 227:522.
335. Rikihisa Y, Perry BD, Cordes DO Rickettsial link with acute equine diarrhea. Vet Rec 1984, 115:390.
336. Rikihisa Y, Perry BD Causative agent of Potomac horse fever. Vet Rec 1984, 115:554.
337. Rikihisa Y, Perry BD Causative ehrlichial organisms in Potomac horse fever. Infect Immun 1985, 49:513.
338. Dutta SK, Myrup AC, Rice RM, et al. Experimental reproduction of Potomac horse fever in horses with a newly isolated Ehrlichia organism. J Clin Microbiol 1985, 22:256.
339. Weiss E, Dasch GA, Kang Y-H, et al. Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by renografin gradient centrifugation. J Bacteriol 1988, 170:5012.
340. Rikihisa Y The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 1991, 4:286.
341. Pretzman C, Ralph D, Stotherd D, et al. 16SrRNA sequence relatedness of Neorickettsia helminthoeca to Ehrlichia risticii and Ehrlichia sennetsu. Int J Syst Bacteriol 1995, 45:207.
342. Rikihisa Y Cross-reacting antigens between Neorickettsia helminthoeca and Ehrlichia spp. shown by immunofluorescence and Western immunoblotting. J Clin Microbiol 1991, 29:2024.
343. Wen B, Rikihisa Y, Yamamoto S, et al. Characterization of SF agent, an Ehrlichia sp. isolated from Stellantchasmus falcatus fluke, by 16S rRNA base sequence, serological, and morphological analysis. Int J Syst Bacteriol 1996, 46:149.
344. Wen B, Rikihisa Y, Fuerst PA, et al. Analysis of 16S rRNA genes of ehrlichial organisms isolated from horses with clinical signs of Potomac horse fever. Int J Syst Bacteriol 1995, 45:315.
345. Rikihisa Y Ehrlichiae of veterinary importance. Rickettsiae and rickettsial diseases at the turn of the third millenium 1999, Elsevier, Paris. D. Raoult, P. Brouqui (Eds.).
346. Rikihisa Y Ultrastructural studies of ehrlichial organisms in the organs of ponies with equine monocytic ehrlichiosis (synonym, Potomac horse fever). Microbiology 1986, American Society of Microbiology, Washington, DC. H. Winkler, M. Ristic (Eds.).
347. Rikihisa Y, Perry BD, Cordes DO Ultrastructural study of rickettsial organisms in the large colon of ponies experimentally infected with Potomac horse fever. Infect Immun 1985, 49:505.
348. Rikihisa Y Ultrastructure of rickettsiae with special emphasis on ehrlichia. Ehrlichiosis: a vector-borne disease of animals and humans 1990, Kluwer Academic, Boston. J.C. Williams, I. Kakoma (Eds.).
349. Rikihisa Y Growth of Ehrlichia risticii in human colonic epithelial cells. Ann N Y Acad Sci 1990, 590:104.
350. Chaichanasiriwithaya W, Rikihisa Y, Yamamoto S, et al. Antigenic, morphologic, and molecular characterization of 9 new Ehrlichia risticii isolates. J Clin Microbiol 1994, 38:3026.
351. Rikihisa Y, Chaichanasiriwithaya W, Reed SM, et al. Distinct antigenic differences of new Ehrlichia risticii isolates. Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, June 8-11, 1994 1994, R&W Publishing, Newmarket, UK.
352. Wells MY, Rikihisa Y Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline. Infect Immun 1988, 56:3209.
353. Lin M, Rikihisa Y Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for Lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun 2003, 71:5324.
354. Weiss E, Williams JC, Dasch GA, et al. Energy metabolism of monocytic Ehrlichia. Proc Natl Acad Sci U S A 1989, 86:1674.
355. Rikihisa Y, Reed SM, Sams RA, et al. Serosurvey of horses with evidence of equine monocytic ehrlichiosis (Potomac horse fever). J Am Vet Med Assoc 1990, 197:1327.
356. Barlough JE, Reubel GH, Madigan JE, et al. Detection of Ehrlichia risticii, the agent of Potomac horse fever, in freshwater stream snails (Pleuroceridae: Juga spp.) of northern California. J Appl Environ Microbiol 1998, 64:2888.
357. Reubel GH, Barlough JE, Madigan JE Production and characterization of Ehrlichia risticii, the agent of Potomac horse fever, from snails (Pleuroceridae: Juga spp.) in aquarium culture and genetic comparison to equine strains. J Clin Microbiol 1998, 36:1501.
358. Kanter M, Mott J, Ohashi N, et al. Analysis of 16S rRNA and 51-kDa antigen gene and transmission in mice of Ehrlichia risticii in virgulate trematodes from Elimia livescens snails in Ohio. J Clin Microbiol 2000, 38:3349.
359. Mott J, Muramatsu Y, Seaton E, et al. Ehrlichemia and clinical signs in horses infected with Ehrlichia risticii by ingestion of adult aquatic insects and molecular comparison of E. risticii in insects, horses, and cell culture. J Clin Microbiol 2002, 40:690.
360. Chae J-S, Pusterla N, Johnson E, et al. Infection of aquatic insects with trematode metacercariae carrying Ehrlichia risticii, the cause of Potomac horse fever. J Med Entomol 2000, 37:619.
361. Madigan JE, Pusterla N, Johnson E, et al. Transmission of Ehrlichia risticii, the agent of Potomac horse fever, using naturally infected aquatic insects and helminth vectors: preliminary report. Equine Vet J 2000, 32:275.
362. Schmidtmann ET, Rice RM, Roble MG, et al. Search for an arthropod vector of Ehrlichia risticii. Proceedings of the Symposium on Potomac Horse Fever 1988, Veterinary Learning Systems, Lawrenceville, NJ.
363. Dawson JE, Abeygunawardena I, Holland CJ Susceptibility of cats to infection with N. risticii, causative agent of equine monocytic ehrlichiosis. Am J Vet Res 1988, 49:2096.
364. Ristic M, Dawson J, Holland CJ, et al. Susceptibility of dogs to infection with Ehrlichia risticii, causative agent of equine monocytic ehrlichiosis (Potomac horse fever). Am J Vet Res 1988, 49:1497.
365. Jenkins SJ, Jones NK, Jenny AL Potomac horse fever agent in mice. Vet Rec 1985, 117:556.
366. Stephenson EH Experimental ehrlichiosis in nonhuman primates. Ehrlichiosis: a vector-borne disease of animals and humans 1990, Kluwer Academic, Boston. J.C. Williams, I. Kakoma (Eds.).
367. Perry BD, Schmidtmann ET, Rice RM, et al. Epidemiology of Potomac horse fever: an investigation into the possible role of non-equine mammals. Vet Rec 1989, 125:83.
368. Kakoma I, Hansen RD, Anderson BE, et al. Cultural, molecular, and immunological characterization of the causative agent for atypical canine ehrlichiosis. J Clin Microbiol 1994, 32:170.
369. Rikihisa Y, Johnson GJ, Burger CJ Reduced immune responsiveness and lymphoid depletion in mice infected with Ehrlichia risticii. Infect Immun 1987, 55:2215.
370. Williams NM, Timoney PJ Variation in susceptibility of ten mouse strains to infection with a strain of Ehrlichia risticii. J Comp Pathol 1994, 110:137.
371. Rikihisa Y, Wada R, Reed SM, et al. Development of neutralizing antibodies in horses infected with Ehrlichia risticii. Vet Microbiol 1993, 36:139.
372. Mott J, Rikihisa Y, Zhang Y Comparison of PCR and culture to indirect fluorescent-antibody test for diagnosis of Potomac horse fever. J Clin Microbiol 1997, 35:2215.
373. Messick JB, Rikihisa Y, Reed SM: Unpublished observation, 1990.
374. Dawson JE, Ristic M, Holland CJ, et al. Isolation of Ehrlichia risticii, the causative agent of Potomac horse fever, from the fetus of an experimentally infected mare. Vet Rec 1987, 121:232.
375. Rikihisa Y, Johnson GJ, Wang Y-Z, et al. Loss of adsorptive capacity for sodium chloride as a cause of diarrhea in Potomac horse fever. Res Vet Sci 1992, 52:353.
376. van Heeckeren A, Rikihisa Y, Park J, et al. Tumor necrosis factor-α, interleukin-1β and prostaglandin E 2 production in murine peritoneal macrophages infected with Ehrlichia risticii. Infect Immun 1993, 61:4333.
377. Rikihisa Y, Perry BD, Lin YC: Increase in intestinal cyclic AMP in mouse model for Potomac horse fever, abstract 1353, annual meeting of the American Society of Cell Biology, Atlanta, 1985. p 357a.
378. Messick JB, Rikihisa Y Characterization of Ehrlichia risticii binding, internalization, and growth in host cells by flow cytometry. Infect Immun 1993, 61:3803.
379. Rikihisa Y, Zhang Y, Park J Role of clathrin, microfilament, and microtubule on infection of mouse peritoneal macrophages with Ehrlichia risticii. Infect Immun 1994, 62:5126.
380. Rikihisa Y, Zhang Y, Park J Role of Ca 2+ and calmodulin on ehrlichial survival in macrophages. Infect Immun 1996, 63:2310.
381. Zhang Y, Rikihisa Y Tyrosine phosphorylation is required for ehrlichial internalization and replication in P388D cells. Infect Immun 1997, 65:2959.
382. Messick JB, Rikihisa Y Inhibition of binding, entry or survival of Ehrlichia risticii in P388D 1 cells by anti- N. risticii IgG and Fab fragments. Infect Immun 1994, 62:3156.
383. Palmer JE, Benson CE, Whitlock RH Resistance to development of equine ehrlichial colitis in experimentally inoculated horses and ponies. Am J Vet Res 1990, 51:763.
384. Pretzman CT, Rikihisa Y, Ralph D, et al. Enzyme-linked immunosorbent assay for detecting Potomac horse fever disease. J Clin Microbiol 1987, 25:31.
385. Messick JB, Rikihisa Y Presence of parasite antigens on the surface of P388D 1 cells infected with Ehrlichia risticii. Infect Immun 1992, 60:3079.
386. Kaylor SP, Crawford TB, McElwain TF, et al. Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis. Infect Immun 1991, 59:2058.
387. Williams NM, Cross RJ, Timoney PJ Respiratory burst activity associated with phagocytosis of Ehrlichia risticii by mouse peritoneal macrophages. Res Vet Sci 1994, 57:194.
388. Williams NM, Timoney PJ In vitro killing of Ehrlichia risticii by activated and immune mouse peritoneal macrophages. Infect Immun 1993, 61:861.
389. Park J, Rikihisa Y L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with interferon-gamma. Infect Immun 1992, 60:3504.
390. Williams NM, Granstrom DE, Timoney PJ Humoral antibody and lymphocyte blastogenesis responses in BALB/c, C3H/HeJ and AKR/N mice following Ehrlichia risticii infection. Res Vet Sci 1994, 56:284.
391. Messick JB, Rikihisa Y Suppression of I-A d on P388D 1 cells by Ehrlichia risticii infection in response to gamma interferon. Vet Immunol Immunopathol 1992, 32:225.
392. Whitlock RH, Palmer JE, Benson CE, et al. Potomac horse fever clinical characteristics and diagnostic features. Proceedings of the twenty-seventh annual meeting of the American Association of Veterinary Laboratory Diagnosticians 1984, 103.
393. Long MT, Goetz TE, Kakoma I, et al. Isolation of Ehrlichia risticii from the aborted fetus of an infected mare. Vet Rec 1992, 131:370.
394. Long MT, Goetz TE, Kakoma I, et al. Evaluation of fetal infection and abortion in pregnant ponies experimentally infected with Ehrlichia risticii. Am J Vet Res 1995, 56:1307.
395. Long MT, Goetz TE, Whitely HE, et al. Identification of Ehrlichia risticii as the causative agent of two equine abortions following natural maternal infection. J Vet Diagn Invest 1995, 7:201.
396. Jernigan A, Rikihisa Y, Hinchcliff KW: Pharmacokinetics of oxytetracycline in ponies with Potomac horse fever. In Proceedings of the seventieth annual meeting and conference of Research Workers in Animal Disease, Chicago, 1989. p 35.
397. Zimmer LE, Whitlock RH, Palmer JE, et al. Clinical and hematologic variables in ponies with experimentally induced equine ehrlichial colitis (Potomac horse fever). Am J Vet Res 1987, 48:63.
398. Ristic M, Holland CJ, Dawson JE, et al. Diagnosis of equine monocytic ehrlichiosis (Potomac horse fever) by indirect immunofluorescence. J Am Vet Med Assoc 1986, 189:39.
399. Rikihisa Y, Reed SM, Sams RA, et al. A serological survey and the clinical management of horses with Potomac horse fever. Proceedings of a Symposium on Potomac Horse Fever 1988, Veterinary Learning Systems, Lawrenceville, NJ.
400. Rikihisa Y, Pretzman CI, Johnson GC, et al. Clinical and immunological responses of ponies to Ehrlichia sennetsu and subsequent Ehrlichia risticii challenge. Infect Immun 1988, 56:2960.
401. Madigan JE, Rikihisa Y, Palmer J Evidence for a high rate of false positive results with the indirect fluorescent antibody test for Ehrlichia risticii antibody in horses. Am J Vet Med Assoc 1995, 207:1448.
402. Holland CJ, Ristic M, Dawson J, et al. Comparative evaluation of the PLAT and IFA test for diagnosis of Potomac horse fever. Proceedings of a Symposium on Potomac Horse Fever 1988, Veterinary Learning Systems, Lawrenceville, NJ.
403. Shankarappa B, Dutta S, Sanusi J, et al. Monoclonal antibody mediated, immunodiagnostic competitive enzyme-linked immunosorbent assay for equine monocytic ehrlichiosis. J Clin Microbiol 1989, 27:24.
404. Dasch GA, Weiss E, Williams JC Antigenic properties of the ehrlichiae and other rickettsiaceae. Ehrlichiosis: a vector-borne disease of animals and humans 1990, Kluwer Academic, Boston. J.C. Williams, I. Kakoma (Eds.).
405. Zhang Y, Ohashi N, Lee EH, et al. Ehrlichia sennetsu groE operon and antigenic properties of the groEL homolog. FEMS Immunol Med Microbiol 1997, 18:39.
406. Vemulapalli R, Biswas B, Dutta SK Cloning and molecular analysis of genes encoding two immunodominant antigens of Ehrlichia risticii. Microb Pathog 1998, 24:361.
407. Dutta SK, Vemulapalli R, Biswas B Assoiation of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses. J Clin Micobiol 1998, 36:506.
408. Barlough JE, Rikihisa Y, Madigan JE Nested polymerase chain reaction for detection of Ehrlichia risticii genomic DNA in infected horses. Vet Parasitol 1997, 68:367.
409. Steele K, Rikihisa Y, Walton A Demonstration of Ehrlichia in Potomac horse fever using a silver stain. Vet Pathol 1986, 23:531.
410. Rikihisa Y, Johnson GC, Reed SM Immune responses and intestinal pathology of ponies experimentally infected with Potomac horse fever. Proceedings of a Symposium on Potomac Horse Fever 1988, Veterinary Learning Systems, Lawrenceville, NJ.
411. Rikihisa Y, Jiang BM In vitro susceptibility of Ehrlichia risticii to eight antibiotics. Antimicrob Agents Chemother 1988, 32:986.
412. Rikihisa Y, Jiang BM Effect of antibiotics on clinical, gross pathologic, and immunologic responses of mice infected with Ehrlichia risticii: protective effects of doxycycline. Vet Microbiol 1989, 19:253.
413. Riond J-L, Riviere JE, Duckett WM, et al. Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses. Equine Vet J 1992, 24:41.
414. Palmer JE, Whitlock RH, Benson CE Clinical signs and treatment of equine ehrlichial colitis. Proceedings of a Symposium on Potomac Horse Fever 1988, Veterinary Learning Systems, Lawrenceville, NJ.
415. Palmer J, Benson C Effect of treatment with erythromycin and rifampin during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 1992, 53:2071.
416. Perry BD, Palmer JE, Troutt HF, et al. A case control study of Potomac horse fever. Prev Vet Med 1986, 4:69.
417. Rikihisa Y Protection against murine Potomac horse fever by an inactivated Ehrlichia risticii vaccine. Vet Microbiol 1991, 28:339.
418. Palmer JE Prevention of Potomac horse fever. Cornell Vet 1989, 79:201. (editorial).
419. Ristic M, Holland CJ, Goetz TE Evaluation of a vaccine for equine monocytic ehrlichiosis. Proceedings of a Symposium on Potomac Horse Fever 1987, 89. Veterinary Learning Systems, Lawrenceville, NJ.
420. Shankarappa B, Dutta SK, Mattingly-Napier B Identification of the protective 44-kilodalton recombinant antigen of Ehrlichia risticii. Infect Immun 1992, 60:612.
421. Gribble DH Equine ehrlichiosis. J Am Vet Med Assoc 1969, 155:462.
422. Buscher G, Gandras R, Apel G, et al. Der erste Fall von Ehrlichiosis beim Pferd in Deutschland (Kurzmitteilung). Dtsch Tierarztl Wochenschr 1984, 91:408.
423. Hermann M, Baumann D, Lutz H, et al. Erster diagnostizierter Fall von equine Ehrlichiose in der Schweiz. Pferdeheilkunde 1985, 1:247.
424. Bjöersdorff A, Christensson D, Johnson A et al: Granulocytic ehrlichiosis in the horse: the first verified cases in Sweden. In Proceedings of fourth international Symposium on Rickettsiae Rickettsial Disease, Piesštaány Spa, Czech and Slovak Federal Republich, 1990. p 69.
425. Gunders AE, Gottlieb D Intra-granulocytic inclusion bodies of Psammomys obesus naturally transmitted by Ornithodoros erraticus (small race). Refuah Vet 1977, 34:5.
426. Munderloh UG, Madigan JE, Dumler JS, et al. Isolation of the equine granulocytic ehrlichiosis agent Ehrlichia equi in tick cell culture. J Clin Microbiol 1996, 34:664.
427. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996, 334:209.
428. Sells DM, Hildebrandt PK, Lewis GE, et al. Ultrastructural observations on Ehrlichia equi organisms in equine granulocytes. Infect Immun 1976, 13:273.
429. Lewis GE Equine ehrlichiosis: a comparison between E. equi and other pathogenic species of Ehrlichia. Vet Parasitol 1976, 2:61.
430. Madigan JE, Hietala S, Chalmers S, et al. Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California. J Am Vet Med Assoc 1990, 196:1962.
431. Richter PJ, Kimsey RB, Madigan JE, et al. Ixodes pacificus as a vector of Ehrlichia equi. J Med Entomol 1995, 33:1.
432. Lewis GE, Huxsoll DL, Ristic M, et al. Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, causative agent of equine ehrlichiosis. Am J Vet Res 1975, 36:85.
433. Reubel GH, Kimsey RB, Barlough JE, et al. Experimental transmission of Ehrlichia equi to horses through naturally infected ticks ( Ixodes pacificus) from northern California. J Clin Microbiol 1998, 36:2131.
434. Stannard AA, Gribble DH, Smith RS Equine ehrlichiosis: a disease with similarities to tick-borne fever and bovine petechial fever. Vet Rec 1969, 84:149.
435. Telford SR, Dawson JE, Katarolos P, et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A 1996, 93:6209.
436. Chae J-S, Foley JE, Dumler JS, et al. Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolated from northern California. J Clin Microbiol 2000, 38:1364.
437. Massung RF, Owens JH, Ross D, et al. Sequence analysis of the ank gene of granulocytic ehrlichiae. J Clin Microbiol 2000, 38:2917.
438. Madigan JE, Richter PJ, Kimsey RB, et al. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995, 172:1141.
439. Nyindo MCA, Ristic M, Lewis GE, et al. Immune responses of ponies to experimental infection with Ehrlichia equi. Am J Vet Res 1978, 39:15.
440. Madigan JE, Gribble D Equine ehrlichiosis in northern California: 49 cases (1968-1981). J Am Vet Med Assoc 1987, 190:445.
441. Zhi N, Ohashi N, Rikihisa Y, et al. Cloning and expression of 44-kDa major outer membrane protein antigen gene of human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol 1998, 36:1666.
442. Barlough JE, Ma JE, DeRock E, et al. Nested polymerase chain reaction for detection of Ehrlichia equi genomic DNA in horses and ticks ( Ixodes pacificus). Vet Parasitol 1996, 63:319.